SCHEMBL29538322

SCHEMBL29538322

C=CC(=O)Nc1cc(Nc2nc(Nc3cnn(C)c3)ncc2-c2ccc(C(F)(F)F)cc2)ccc1F

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 4/20 0.58
▸ EGFR P00533 3/20 0.50
▸ MERTK Q12866 5/20 0.48
▸ MAP3K7 O43318 4/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ MAP2K1 Q02750 1/20 0.47
▸ FGFR1 P11362 3/20 0.46
▸ SRC P12931 3/20 0.46
▸ KDR P35968 1/20 0.46
▸ TYRO3 Q06418 5/20 0.46
▸ DDR2 Q16832 1/20 0.46
▸ JAK2 O60674 1/20 0.45
▸ JAK1 P23458 1/20 0.45
▸ TTK P33981 1/20 0.45
▸ AXL P30530 3/20 0.45
▸ BTK Q06187 2/20 0.45
▸ BMX P51813 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24392761 1.00 JAK3 (0.58) JAK3EGFRMERTKMAP3K7MAPK1
Pebezertinib SCHEMBL24392854 0.94 JAK3 (0.54) JAK3EGFRMERTKMAP3K7MAPK1
Pebezertinib SCHEMBL29537331 0.89 JAK3 (0.49) JAK3EGFRMAP3K7FGFR1SRC
Pebezertinib SCHEMBL29538037 0.89 JAK3 (0.49) JAK3MERTKMAP3K7FGFR1SRC
SCHEMBL24392985 0.88 JAK3 (0.50) JAK3EGFRMERTKMAP3K7MAPK1
SCHEMBL24392974 0.88 EGFR (0.57) JAK3EGFRMERTKTYRO3DDR2
SCHEMBL29538169 0.88 EGFR (0.57) JAK3EGFRMERTKTYRO3DDR2
SCHEMBL24392710 0.88 JAK3 (0.53) JAK3EGFRMAP3K7MAPK1MAP2K1
SCHEMBL24393004 0.88 JAK3 (0.54) JAK3EGFRMAP3K7MAPK1MAP2K1
SCHEMBL24392817 0.87 MERTK (0.49) JAK3EGFRMERTKMAP3K7MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4237418-A1 PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF Blueprint Medicines Corporation (US) 2023-09-06 — — EP disclosed
WO-2022094354-A1 PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF LENGO THERAPEUTICS, INC. (US) 2022-05-05 — — WO disclosed
Send feedback